#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5225305	F	Antiinflammatory activity in mouse J774.A1 cells assessed as decrease in LPS-induced IL-6 secretion at 20 uM preincubated for 30 mins followed by LPS stimulation and measured after 24 hrs by ELISA	Mus musculus	37		cell-based format	Scientific Literature
2.	ALA5225306	F	Antiinflammatory activity in mouse J774.A1 cells assessed as decrease in LPS-induced TNF-alpha secretion at 20 uM preincubated for 30 mins followed by LPS stimulation and measured after 24 hrs by ELISA	Mus musculus	37		cell-based format	Scientific Literature
3.	ALA5225307	F	Antiinflammatory activity in mouse J774.A1 cells assessed as decrease in LPS-induced IL-6 secretion preincubated for 30 mins followed by LPS stimulation and measured after 24 hrs by ELISA	Mus musculus	4		cell-based format	Scientific Literature
4.	ALA5225308	F	Antiinflammatory activity in mouse J774.A1 cells assessed as decrease in LPS-induced TNF-alpha secretion preincubated for 30 mins followed by LPS stimulation and measured after 24 hrs by ELISA	Mus musculus	4		cell-based format	Scientific Literature
5.	ALA5225309	F	Antiinflammatory activity in C57BL/6J mouse model of LPS-induced acute lung injury assessed as reduction in neutrophil count in BALF at 20 mg/kg, po administered 30 mins prior to LPS treatment and measured after 6 hrs by Wright and Giemsa staining based analysis	Mus musculus	2		organism-based format	Scientific Literature
6.	ALA5225310	F	Antiinflammatory activity in C57BL/6J mouse model of LPS-induced acute lung injury assessed as reduction in TNF-alpha production in BALF at 20 mg/kg, po administered 30 mins prior to LPS treatment and measured after 6 hrs	Mus musculus	1		organism-based format	Scientific Literature
7.	ALA5225311	F	Antiinflammatory activity in C57BL/6J mouse model of LPS-induced acute lung injury assessed as reduction in IL-6 production in BALF at 20 mg/kg, po administered 30 mins prior to LPS treatment and measured after 6 hrs	Mus musculus	1		organism-based format	Scientific Literature
8.	ALA5225312	F	Antiinflammatory activity in C57BL/6J mouse model of LPS-induced acute lung injury assessed as reduction in TNF-alpha production in serum at 20 mg/kg, po administered 30 mins prior to LPS treatment and measured after 6 hrs	Mus musculus	1		organism-based format	Scientific Literature
9.	ALA5225313	F	Antiinflammatory activity in C57BL/6J mouse model of LPS-induced acute lung injury assessed as reduction in IL-6 production in serum at 20 mg/kg, po administered 30 mins prior to LPS treatment and measured after 6 hrs	Mus musculus	1		organism-based format	Scientific Literature
10.	ALA5225314	F	Antiinflammatory activity in C57BL/6J mouse model of LPS-induced acute lung injury assessed as reduction in alveolar septa thickness at 20 mg/kg, po administered 30 mins prior to LPS treatment and measured after 6 hrs by H and E staining based assay	Mus musculus	1		organism-based format	Scientific Literature
11.	ALA5225315	F	Antiinflammatory activity in C57BL/6J mouse model of LPS-induced acute lung injury assessed as reduction in pulmonary congestion at 20 mg/kg, po administered 30 mins prior to LPS treatment and measured after 6 hrs by H and E staining based assay	Mus musculus	1		organism-based format	Scientific Literature
12.	ALA5225316	F	Antiinflammatory activity in C57BL/6J mouse model of LPS-induced acute lung injury assessed as reduction in inflammatory infiltration at 20 mg/kg, po administered 30 mins prior to LPS treatment and measured after 6 hrs by H and E staining based assay	Mus musculus	1		organism-based format	Scientific Literature
13.	ALA5225317	F	Antiinflammatory activity in C57BL/6J mouse model of LPS-induced acute lung injury assessed as reduction in tissue destruction at 20 mg/kg, po administered 30 mins prior to LPS treatment and measured after 6 hrs by H and E staining based assay	Mus musculus	1		organism-based format	Scientific Literature
14.	ALA5225318	F	Antiinflammatory activity in C57BL/6J mouse model of LPS-induced acute lung injury assessed as reduction in neutrophil infiltration at 20 mg/kg, po administered 30 mins prior to LPS treatment and measured after 6 hrs by F4/80 antibody staining based assay	Mus musculus	2		organism-based format	Scientific Literature
15.	ALA5225319	F	Antiinflammatory activity in C57BL/6J mouse model of LPS-induced acute lung injury assessed as reduction in p-p65 level at 20 mg/kg, po administered 30 mins prior to LPS treatment and measured after 6 hrs by immunohistochemical analysis	Mus musculus	2		organism-based format	Scientific Literature